Abstract: A computer system, while displaying a first user interface, detects a first portion of a first input. In response, the computer system, in accordance with a determination that the first portion of the first input meets first criteria, displays a first portion of a transition to a second user interface that is different from the first user interface, and then, in response to detecting a second portion of the first input that is a continuation of the first portion of the first input, in accordance with a determination that the first input meets second criteria, completes the transition to displaying the second user interface.

Abstract: A combined gas-compressor and dehumidifier system composed of a gas compressor for compressing a first gas, a dehumidifier for dehumidifying a second gas, and a cooling system. The gas compressor is composed of one or more compression stages and one or more intercoolers, wherein the one or more intercoolers are connected to a cooling system. The dehumidifier for dehumidifying a second gas is composed of a first dehumidifying stage that uses a first desiccant to adsorb water from the second gas and output a second intermediate gas, a second dehumidifying stage that uses a second desiccant to adsorb water from the second intermediate gas, and a waste heat exchanger, wherein the waste heat exchanger is used to reactivate the first desiccant. The cooling system is composed of a liquid contained in connectors, and the connectors connecting the one or more intercoolers to remove heat from the gas compressor and provide the removed heat to the dehumidifier.

Abstract: A combined gas-compressor and dehumidifier system composed of a gas compressor for compressing a first gas, a dehumidifier for dehumidifying a second gas, and a cooling system. The gas compressor is composed of (a) one or more compression stages and (b) one or more intercoolers, wherein the one or more intercoolers are connected to a cooling system. The dehumidifier for dehumidifying a second gas is composed of a first dehumidifying stage that uses a first desiccant to adsorb water from the second gas and output a second intermediate gas, a second dehumidifying stage that uses a second desiccant to adsorb water from the second intermediate gas, and a waste heat exchanger, wherein the waste heat exchanger is used to reactivate the first desiccant. The cooling system is composed of a liquid contained in connectors, and the connectors connecting the one or more intercoolers to remove heat from the gas compressor and provide the removed heat to the dehumidifier.

Abstract: A method of preparing cocoa oligomeric procyanidins from cocoa cell cultures grown in the presence of monosaccharide can increase production of procyanidins as follows: culturing cells sufficient to result in production of cocoa oligomeric procyanidins at a first rate; and introducing a monosaccharide to the cells sufficient for inducing the cells to produce the cocoa oligomeric procyanidins at a second rate that his higher than the first rate. The method can further include extracting the cocoa oligomeric procyanidins from the cells, and such extracting can occur between 1 day to 21 days after introduction of the monosaccharide. Optionally, the monosaccharide can be introduced in an amount about 0.5% to about to about 20% by volume of the culture medium. The monosaccharide can be glucose, sucrose, fructose, or the like. The monosaccharide can be introduced during or after a last phase of an exponential growth state.

Abstract: A method of preparing cocoa oligomeric procyanidins from cocoa cell cultures grown in the presence of monosaccharide can increase production of procyanidins as follows: culturing cells sufficient to result in production of cocoa oligomeric procyanidins at a first rate; and introducing a monosaccharide to the cells sufficient for inducing the cells to produce the cocoa oligomeric procyanidins at a second rate that his higher than the first rate. The method can further include extracting the cocoa oligomeric procyanidins from the cells, and such extracting can occur between 1 day to 21 days after introduction of the monosaccharide. Optionally, the monosaccharide can be introduced in an amount about 0.5% to about to about 20% by volume of the culture medium. The monosaccharide can be glucose, sucrose, fructose, or the like. The monosaccharide can be introduced during or after a last phase of an exponential growth state.

Abstract: The invention relates to nitrogenous heterocyclic compounds of formula (I): in which: R1 represents hydrogen, —(CH2)m—NH2, —(CH2)m—NH(C1-C6)alk, —(CH2)m—N(C1-C6)alk2, —(CH2)m—NH—C(NH)NH2 or —(CH2)m—NH—CH?NH, m is equal to 1 or 2; R2 and R3 together form a nitrogenous heterocycle of aromatic character with 5 vertices containing 1, 2 or 3 nitrogen atoms, substituted on a nitrogen atom by R4; R4 represents hydrogen, C1-C6)alk or a chain of formula: -(A)n-(NH)o—(CH2)p—(CHR?)qR? A represents C?O, C?NH or SO2; R? represents hydrogen or carboxy.

Abstract: The invention relates to nitrogen-containing heterocyclic compounds of general formula (I) wherein: R1 represents a (CH2)n—NH2 radical, n being equal to 1 or 2; R2 represents a hydrogen atom; R3 and R4 form together a nitrogen-containing heterocycle with aromaticity with 5 apices containing 1, 2 or 3 nitrogen atoms, substituted on this nitrogen atom or one of these nitrogen atoms with a (CH2)m—(C(O))p—R5 group, m being equal to 0, 1, 2 or 3, p being equal to 0 or 1 and R5 representing a hydroxy group, in which case p is equal to 1, or an amino, (C1-C6)alkyl or di-(C1-C6)alkyl amino, a nitrogen-containing heterocycle with aromaticity with 5 or 6 apices containing 1 or 2 nitrogen atoms and if necessary, an oxygen or sulfur atom; it being understood that when the sub-group (C(O))p—R5 forms a carboxy, amino, (C1-C6) alkyl or di-(C1-C6) alkyl amino, group, m is different from 0 or 1; in free form or as zwitterions and salts with pharmaceutically acceptable mineral or organic bases and acids, to their pre

Abstract: The invention concerns nitrogenated heterocyclic compounds, their preparation and use as antibacterial drugs, compounds of general formula (I) wherein R1 represents a (CH2)n-NHR2 or (CH2)n-NHR radical, where R is a (C1-C6) alkyl and n is equal to 1 or 2; R2 represents a hydrogen atom; R3 and R4 together form an aromatic nitrogenated heterocycle with 5 apexes with 1, 2 or 3 nitrogen atoms optionally substituted by one or several R? groups, R? being selected in the group composed of a hydrogen atom and alkyl radicals with 1 to 6 carbon atoms; in free form, as zwitterions, and in the form of salts of pharmaceutically acceptable inorganic or organic bases and acids.

Abstract: The invention concerns nitrogenated heterocyclic compounds, their preparation and use as antibacterial drugs, compounds of general formula (I) wherein R1 represents a (CH2)n—NH2 or (CH2)n—NHR radical, where R is a (C1-C6) alkyl and n is equal to 1 or 2; R2 represents a hydrogen atom; R3 and R4 together form an aromatic nitrogenated heterocycle with 5 apexes with 1, 2 or 3 nitrogen atoms optionally substituted by one or several R? groups, R? being selected in the group composed of a hydrogen atom and alkyl radicals with 1 to 6 carbon atoms; in free form, as zwitterions, and in the form of salts of pharmaceutically acceptable inorganic or organic bases and acids.

Abstract: The invention relates to nitrogenous heterocyclic compounds of formula in which: R1 represents hydrogen, —(CH2)m—NH2, —(CH2)m—NH(C1-C6)alk, —(CH2)m—N(C1-C6)alk2, —(CH2)m—NH—C(NH)NH2 or —(CH2)m—NH—CH?NH, m is equal to 1 or 2; R2 and R3 together form a nitrogenous heterocycle of aromatic character with 5 vertices containing 1, 2 or 3 nitrogen atoms, substituted on a nitrogen atom by R4; R4 represents hydrogen, C1-C6)alk or a chain of formula: -(A)n-(NH)o—(CH2)p—(CHR?)qR? A represents C?O, C?NH or SO2; R? represents hydrogen or carboxy.

Abstract: The invention relates to nitrogen-containing heterocyclic compounds of general formula (I) wherein: R1 represents a (CH2)n—NH2 radical, n being equal to 1 or 2; R2 represents a hydrogen atom; R3 and R4 form together a nitrogen-containing heterocycle with aromaticity with 5 apices containing 1, 2 or 3 nitrogen atoms, substituted on this nitrogen atom or one of these nitrogen atoms with a (CH2)m—(C(O))p—R5 group, m being equal to 0, 1, 2 or 3, p being equal to 0 or 1 and R5 representing a hydroxy group, in which case p is equal to 1, or an amino, (C1-C6)alkyl or di-(C1-C6)alkyl amino, a nitrogen-containing heterocycle with aromaticity with 5 or 6 apices containing 1 or 2 nitrogen atoms and if necessary, an oxygen or sulfur atom; it being understood that when the sub-group (C(O))p—R5 forms a carboxy, amino, (C1-C6) alkyl or di-(C1-C6) alkyl amino, group, m is different from 0 or 1; in free form or as zwitterions and salts with pharmaceutically acceptable mineral or organic bases and acids, to their prepara

Abstract: A system and method for receiving and displaying computer animations and graphical user interfaces, comprising interactive, animated, semi-transparent graphics and/or combined text or other displayable information. The animations are received from a data storage system or a network through a data stream, and possibly created, modified and destroyed either through the data stream or as a consequence of a user action on the interactive items. In addition, the animations are intended to be semi-transparently displayed over a background video content, either in a single or in a set of digital video file(s) or stream(s).

Abstract: A bearing assembly comprises clearance-tree outer and inner ball raceways which define outer and inner rings supporting the inner and outer spherical and eccentric annular spaces, and eccentric outer and inner ball raceways respectively arranged in the outer and annular spaces, and elements for tilting by sliding the eccentric outer and inner ball raceways, to compensate run-outs. The invention is applicable to ball-, roller- or needle-antifriction bearings.

Abstract: (R)-Ifosfamide is administered as a cytotoxic drug, in order to minimize side effects. (S)-Ifosfamide may be administered subsequently.